Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma

NCT00504140 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma

Interventions

DRUG: Etoposide
DRUG: Interferon Alpha

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]